Valuation: Divi's Laboratories Limited

Market Cap 2,13900Cr 2.24TCr 1.95TCr 1.81TCr 1.66TCr 3.14TCr 3.19TCr 21TCr 8.39TCr 1,06500Cr 8.41TCr 8.23TCr 3,57000Cr P/E 2027 *
71.5x
P/E 2028 * 58.5x
Enterprise Value 2,10500Cr 2.21TCr 1.92TCr 1.78TCr 1.64TCr 3.09TCr 3.14TCr 21TCr 8.25TCr 1,04800Cr 8.28TCr 8.1TCr 3,51400Cr EV / Sales 2027 *
17.2x
EV / Sales 2028 * 14.5x
Free-Float
48%
Yield 2027 *
0.44%
Yield 2028 * 0.5%
1 day+2.82%
1 week+11.14%
1 month+22.45%
3 months+23.89%
6 months+33.14%
Current year+26.02%
1 week 7,220.5
Extreme 7220.5
8,090
1 month 6,545
Extreme 6545
8,090
Current year 5,647.5
Extreme 5647.5
8,090
1 year 5,636.5
Extreme 5636.5
8,090
3 years 3,295.3
Extreme 3295.3
8,090
5 years 2,730
Extreme 2730
8,090
10 years 532.65
Extreme 532.65
8,090
Manager TitleAgeSince
Chief Executive Officer 75 26/11/2009
Chief Executive Officer 48 04/01/2020
Director of Finance/CFO 65 01/08/2025
Director TitleAgeSince
Director/Board Member 48 26/11/2009
Chairman 75 26/11/2009
Director/Board Member 68 01/10/1994
Date Insider Type Main position Quantity % Market Cap.
26/03/25 Sell

Executive/Senior Manager

25,000 0.0094%
15/03/25 Sell 300 0.0001%
17/02/25 Sell 500 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
+2.82%+11.14%+22.14%+118.66% 2.24TCr
-0.53%-3.95%+55.23%+152.74% 1,02400Cr
+0.21%-2.68%+55.61%+53.02% 62TCr
-2.51%-3.25%+32.76%+67.76% 44TCr
+0.06%-0.42%+37.53%+30.67% 35TCr
-0.14%-0.24%+34.41%+39.01% 30TCr
-0.69%-0.30%+11.55%+12.93% 26TCr
-7.37%-4.40%-2.54%-43.87% 21TCr
-0.64%+2.43%+30.52%+64.49% 21TCr
-0.82%+0.70%+15.96%+71.01% 16TCr
Average -0.96%+0.04%+29.32%+56.64% 35.96TCr
Weighted average by Cap. -0.96%-1.85%+39.13%+73.24%

Financials

2027 *2028 *
Net sales 12TCr 128.35Cr 111.57Cr 103.85Cr 95Cr 180.06Cr 182.85Cr 1.22TCr 480.44Cr 6.1TCr 482.03Cr 471.44Cr 20TCr 15TCr 151.93Cr 132.07Cr 122.93Cr 112.86Cr 213.14Cr 216.44Cr 1.45TCr 568.7Cr 7.22TCr 570.58Cr 558.05Cr 24TCr
Net income 3.02TCr 32Cr 28Cr 26Cr 24Cr 44Cr 45Cr 302.09Cr 118.56Cr 1.51TCr 118.95Cr 116.34Cr 5.05TCr 3.7TCr 39Cr 34Cr 31Cr 29Cr 54Cr 55Cr 369.93Cr 145.19Cr 1.84TCr 145.67Cr 142.47Cr 6.18TCr
Net Debt -3.35TCr -35Cr -31Cr -28Cr -26Cr -49Cr -50Cr -334.67Cr -131.35Cr -1.67TCr -131.78Cr -128.89Cr -5.59TCr -4.21TCr -44Cr -38Cr -36Cr -33Cr -62Cr -63Cr -420.98Cr -165.22Cr -2.1TCr -165.77Cr -162.13Cr -7.03TCr
Logo Divi's Laboratories Limited
Divi's Laboratories Limited is specialized in the development and manufacture of active pharmaceutical ingredients, intermediates and nutraceutical ingredients. Net sales by source of revenue break down into product sales (97.9%) and service sales (2.1%). At the end of March 2020, the group has 2 production sites located in India.
Employees
11,565
Date Price Change Volume
31/26/31 ₹8,056.00 +2.82% 7,93,919
30/26/30 ₹7,835.00 +0.65% 6,51,446
29/26/29 ₹7,784.50 +4.84% 11,58,131
28/26/28 ₹7,425.00 +0.15% 4,10,385
27/26/27 ₹7,414.00 +2.28% 5,44,701
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
8,056.00INR
Average target price
7,198.80INR
Spread / Average Target
-10.64%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DIVISLAB Stock